This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
29 Oct 2019

The Leader in Spray Drying

Hovione continues to lead in Spray Drying, thanks to the largest capacity, the most experienced team of scientists that keep coming up with innovative solutions and the best-scale up science.

We can take a product from lab to commercial scale within an end-to-end solution that takes place in the same site.

Spray drying is used in a multitude of pharmaceutical applications and is one of the preferred techniques used to improve the bioavailability for compounds with low solubility and for the production of inhalable dry powder formulations.

Hovione has a unique value proposition when it comes to processing amorphous solid dispersions. Our Company has a proven track record with commercial spray drying over the last 16 years. Having executed more than 250 tech transfer and scale-up projects, we have unrivaled experience in development, industrialization and manufacturing of processes that use the spray drying technology. To date, we have supported numerous process validations and regulatory submissions with successful marketing authorization.

Hovione has spray drying facilities in Portugal, Ireland and the U.S. covering all of the requirements of the pharmaceutical market in terms of scale, bioburden control and ability to handle highly potent materials. Further to our expertise in Spray-Drying, in the Inhalation area Hovione is the only independent company offering a complete range of services along with a full range of simple, patented, cost-effective DPIs.

As a specialist integrated CDMO, Hovione is increasingly being chosen as a solution partner from Drug Substance to Drug Product Intermediate to Drug Product. Hovione ‘One-Site-Stop’ allows customers to streamline their supply chain, reduce time to market and benefit from seamless project management. “Our customers now see drug product manufacturing at the site where they produce their drug product intermediate as a natural extension of the range of value added services they expect from us. They want to keep their product in the same capable hands”, says Frédéric Kahn, Vice President Marketing and Sales at Hovione.

Celebrating its 60th anniversary this year, Hovione also celebrates a flawless regulatory track record (34 USFDA inspections since 1982) and an unblemished history regarding products and inspections with no recalls or warning letters. This is in line with the unrelenting excellence of service we wish to provide to our customers and to people’s health. After all, we are “In it for Life”.


Mentioned Companies
Hovione FarmaCiencia SA
View company profile